Psyence Biomedical Ltd. (PBM) P/E Ratio History
Deep ValueTrading at -0.2x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2024–2025
Loading P/E history...
P/E Ratio Analysis
The current P/E is 100% below its 5-year average of 80.3x. Over the past five years, PBM's P/E has ranged from a low of 11.9x to a high of 148.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 24.6x, PBM trades at a 101% discount to its sector peers. The sector includes 242 companies with P/E ratios ranging from 0.0x to 196.0x.
Relative to the broader market, PBM trades at a notable discount to the S&P 500 median P/E of 21.8x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PBM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
PBM Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
PBM P/E vs Peers
Psychiatry & Psychedelic Drugs peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $14B | 337.5 | - | -95% | |
| $15B | 73.7 | - | -168% | |
| $1B | 7.1Lowest | 0.69Best | +817%Best | |
| $31M | 15.0 | - | -77% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
PBM Historical P/E Data (2024–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q2 | - | $19.20 | $1.62 | 11.9x | -85% |
| FY2024 Q2 | Sep 30 2024 | $315.00 | $2.12 | 148.7x | +85% |
Average P/E for displayed period: 80.3x
PBM Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
2+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PBM — Frequently Asked Questions
Quick answers to the most common questions about buying PBM stock.
What is PBM's P/E ratio?
Psyence Biomedical Ltd. (PBM) trailing twelve-month P/E ratio is -0.2x, based on TTM diluted EPS of N/A. The 5-year average P/E is 80.3x and the historical range spans 11.9x to 148.7x.
Is PBM stock overvalued or undervalued?
PBM trades at -0.2x P/E, below its 5-year average of 80.3x. At the 0th percentile of its historical range (11.9x–148.7x), the stock is priced at a discount to its own history.
Is PBM stock expensive?
No, PBM is not expensive on a historical basis. The current P/E of -0.2x is below the 5-year average of 80.3x and sits at the 0th percentile of its valuation range.
What is PBM's historical P/E range?
Over the past 5 years, PBM's P/E ratio has ranged from 11.9x to 148.7x, with a median of 148.7x and an average of 80.3x. The current P/E of -0.2x places the stock at the 0th percentile of this range. Full historical data spans 2024–2025.
How does PBM's P/E compare to the S&P 500?
PBM trades at -0.2x P/E versus the S&P 500 median of 21.8x. The 101% discount to the market suggests lower growth expectations or perceived higher risk.
How does PBM's valuation compare to Healthcare peers?
Psyence Biomedical Ltd. P/E of -0.2x compares to the Healthcare sector median of 24.6x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is PBM's PEG ratio?
PBM PEG ratio is N/A, based on a P/E of -0.2x and EPS growth of -805.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is PBM's earnings yield?
PBM earnings yield is N/A, the inverse of its -0.2x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.